Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,154.01
    -3,105.35 (-3.60%)
     
  • CMC Crypto 200

    1,262.03
    -95.98 (-7.07%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

Company News For Jul 3, 2018

Some investors are rotating out of earlier high flying technology stocks into cheap emerging markets.
  • Core Laboratories N.V.’s CLB shares declined 10.8% after the company trimmed its second quarter revenue guidance from $177 million-$179 million to $174 million-$175 million

  • Shares of Alkermes plc ALKS jumped 1.8% on approval from the U.S. Food and Drug Administration (FDA) for its long-acting injectable atypical antipsychotic drug for the treatment of schizophrenia in adults

  • Acxiom Corporation’s ACXM shares jumped 14.2% on news that the company is nearing a deal to sell its marketing solutions division to Interpublic Group for $2.2 billion

  • Shares of United Rentals, Inc. URI declined 1.9% after the company agreed to buy BakerCorp International Holdings Inc. for $715 million in cash


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Acxiom Corporation (ACXM) : Free Stock Analysis Report
 
United Rentals, Inc. (URI) : Free Stock Analysis Report
 
Alkermes plc (ALKS) : Free Stock Analysis Report
 
Core Laboratories N.V. (CLB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research